April 8, 2013
/PRNewswire/ -- Andrew Technologies announces the first availability of the HydraSolve™ Lipoplasty System in central
at Bougainvillea Clinique in
Winter Park, FL
has now purchased and accepted delivery of central
's first available HydraSolve™ Lipoplasty System.
HydraSolve™ is a novel liposuction device based on the same patented Tissue Liquefaction Technology™ that was launched in 2003 by Alcon as the AquaLase
Liquefaction Device, a modality on the Infiniti Vision System, for precision cataract surgery. Hydrasolve™ combines natural saline solution with low levels of pressure and temperature, to liquefy only targeted fat tissue. Because fat tissue is liquefied, the cutting of fat by forceful thrusts of the cannula is no longer required. The specially designed HydraSolve™ cannula is manufactured with aperture edges that have a rounded radius of curvature that do not cut tissue. It is the energized saline stream, inside the cannula, that liquefies targeted fat tissue while preserving blood vessels, nerves and connective tissue integrity. HydraSolve™ achieves liquefaction of fat tissue by cell disaggregation, not by emulsification and the lysing of cell membranes.
, M.D., is the director of the Bougainvillea Clinique in
and is a plastic surgeon who has received training all over the world, from
Johannesburg, South Africa
where he grew up and where he completed his early training in dentistry, to
Salt Lake City
, where he received his medical and plastic surgery training. The training and education Dr. Hartog has received sets him apart from many doctors and plastic surgeons. Aside from having dual board certifications in Plastic Surgery and Oral and Maxillofacial Surgery, Dr. Hartog has also completed residencies in four different specialties-Plastic and Reconstructive Surgery at the
University of Utah
, General Surgery at the
Medical Center, Oral and Maxillofacial Surgery at the
University of Miami
, and Anesthesiology at the
University of Miami
. Dr. Hartog has become an acknowledged specialist in the emerging field of Regenerative Cosmetic and Reconstructive Surgery. This field centers around the use of fat grafting in all aspects of plastic surgery, including breast reconstruction and augmentation, facial and skin rejuvenation, body contouring, radiation damage, scar treatments, and wound healing.
Mark S. Andrew
, Founder and Chief Scientific Officer of Andrew Technologies stated, "Dr. Hartog is a highly educated and skilled plastic surgeon with a keen focus on aesthetic body contouring and on regenerative medicine. So, we are thrilled to have Dr. Hartog as our sole provider of HydraSolve™ liposuction in the central
area during our Expert Release program." According to the Dr. Hartog, "From my clinical experience, I have found that HydraSolve™ provides a more gentle liposuction body contouring procedure than any other existing technology, with the least amount of damage to surrounding tissues. The result is little or no bruising, minimal discomfort, rapid recovery and superior results."
About Andrew Technologies, LLC
Andrew Technologies, founded in 2007, is a medical technology company committed to improving patients' lives through body aesthetics and pursuit of surgical applications of Tissue Liquefaction Technology. Andrew Technologies is a venture capital funded company based in
Orange County, CA
. Our primary investors are WFD Ventures
and NJTC Venture Fund
SOURCE Andrew Technologies